These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34031362)

  • 1. Multimodal prognosis of negative symptom severity in individuals at increased risk of developing psychosis.
    Hauke DJ; Schmidt A; Studerus E; Andreou C; Riecher-Rössler A; Radua J; Kambeitz J; Ruef A; Dwyer DB; Kambeitz-Ilankovic L; Lichtenstein T; Sanfelici R; Penzel N; Haas SS; Antonucci LA; Lalousis PA; Chisholm K; Schultze-Lutter F; Ruhrmann S; Hietala J; Brambilla P; Koutsouleris N; Meisenzahl E; Pantelis C; Rosen M; Salokangas RKR; Upthegrove R; Wood SJ; Borgwardt S;
    Transl Psychiatry; 2021 May; 11(1):312. PubMed ID: 34031362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression: A Multimodal, Multisite Machine Learning Analysis.
    Koutsouleris N; Kambeitz-Ilankovic L; Ruhrmann S; Rosen M; Ruef A; Dwyer DB; Paolini M; Chisholm K; Kambeitz J; Haidl T; Schmidt A; Gillam J; Schultze-Lutter F; Falkai P; Reiser M; Riecher-Rössler A; Upthegrove R; Hietala J; Salokangas RKR; Pantelis C; Meisenzahl E; Wood SJ; Beque D; Brambilla P; Borgwardt S;
    JAMA Psychiatry; 2018 Nov; 75(11):1156-1172. PubMed ID: 30267047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting psychosis in a general adolescent psychiatric sample.
    Lindgren M; Manninen M; Kalska H; Mustonen U; Laajasalo T; Moilanen K; Huttunen M; Cannon TD; Suvisaari J; Therman S
    Schizophr Res; 2014 Sep; 158(1-3):1-6. PubMed ID: 25015028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward Generalizable and Transdiagnostic Tools for Psychosis Prediction: An Independent Validation and Improvement of the NAPLS-2 Risk Calculator in the Multisite PRONIA Cohort.
    Koutsouleris N; Worthington M; Dwyer DB; Kambeitz-Ilankovic L; Sanfelici R; Fusar-Poli P; Rosen M; Ruhrmann S; Anticevic A; Addington J; Perkins DO; Bearden CE; Cornblatt BA; Cadenhead KS; Mathalon DH; McGlashan T; Seidman L; Tsuang M; Walker EF; Woods SW; Falkai P; Lencer R; Bertolino A; Kambeitz J; Schultze-Lutter F; Meisenzahl E; Salokangas RKR; Hietala J; Brambilla P; Upthegrove R; Borgwardt S; Wood S; Gur RE; McGuire P; Cannon TD
    Biol Psychiatry; 2021 Nov; 90(9):632-642. PubMed ID: 34482951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of psychosis in prodrome: development and validation of a simple, personalized risk calculator.
    Zhang T; Xu L; Tang Y; Li H; Tang X; Cui H; Wei Y; Wang Y; Hu Q; Liu X; Li C; Lu Z; McCarley RW; Seidman LJ; Wang J;
    Psychol Med; 2019 Sep; 49(12):1990-1998. PubMed ID: 30213278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression.
    Koutsouleris N; Dwyer DB; Degenhardt F; Maj C; Urquijo-Castro MF; Sanfelici R; Popovic D; Oeztuerk O; Haas SS; Weiske J; Ruef A; Kambeitz-Ilankovic L; Antonucci LA; Neufang S; Schmidt-Kraepelin C; Ruhrmann S; Penzel N; Kambeitz J; Haidl TK; Rosen M; Chisholm K; Riecher-Rössler A; Egloff L; Schmidt A; Andreou C; Hietala J; Schirmer T; Romer G; Walger P; Franscini M; Traber-Walker N; Schimmelmann BG; Flückiger R; Michel C; Rössler W; Borisov O; Krawitz PM; Heekeren K; Buechler R; Pantelis C; Falkai P; Salokangas RKR; Lencer R; Bertolino A; Borgwardt S; Noethen M; Brambilla P; Wood SJ; Upthegrove R; Schultze-Lutter F; Theodoridou A; Meisenzahl E;
    JAMA Psychiatry; 2021 Feb; 78(2):195-209. PubMed ID: 33263726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical high-risk criteria of psychosis in 8-17-year-old community subjects and inpatients not suspected of developing psychosis.
    Schultze-Lutter F; Walger P; Franscini M; Traber-Walker N; Osman N; Walger H; Schimmelmann BG; Flückiger R; Michel C
    World J Psychiatry; 2022 Mar; 12(3):425-449. PubMed ID: 35433326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and prediction of clinical high risk of psychosis in Chinese outpatients using two-stage screening.
    Xu L; Wang Y; Cui H; Tang Y; Wang J; Tang X; Zhang B; Wei Y; Zhu Y; Jiang L; Qian Z; Li H; Zhang T; Wang J
    Schizophr Res; 2018 Dec; 202():284-290. PubMed ID: 29929774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of attenuated positive and negative symptoms in individuals at clinical high risk: Associations with risk of conversion to psychosis and functional outcome.
    Carrión RE; Demmin D; Auther AM; McLaughlin D; Olsen R; Lencz T; Correll CU; Cornblatt BA
    J Psychiatr Res; 2016 Oct; 81():95-101. PubMed ID: 27424062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor Analysis of Negative Symptom Items in the Structured Interview for Prodromal Syndromes.
    Azis M; Strauss GP; Walker E; Revelle W; Zinbarg R; Mittal V
    Schizophr Bull; 2019 Sep; 45(5):1042-1050. PubMed ID: 30535399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Checking the predictive accuracy of basic symptoms against ultra high-risk criteria and testing of a multivariable prediction model: Evidence from a prospective three-year observational study of persons at clinical high-risk for psychosis.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Eur Psychiatry; 2017 Sep; 45():27-35. PubMed ID: 28728092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning.
    Brodey BB; Girgis RR; Favorov OV; Addington J; Perkins DO; Bearden CE; Woods SW; Walker EF; Cornblatt BA; Brucato G; Walsh B; Elkin KA; Brodey IS
    Schizophr Res; 2018 Jul; 197():516-521. PubMed ID: 29358019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term functional outcome and premorbid adjustment in clinical high-risk patients. Results of the EPOS project.
    Salokangas RK; Heinimaa M; From T; Löyttyniemi E; Ilonen T; Luutonen S; Hietala J; Svirskis T; von Reventlow HG; Juckel G; Linszen D; Dingemans P; Birchwood M; Patterson P; Schultze-Lutter F; Ruhrmann S; Klosterkötter J;
    Eur Psychiatry; 2014 Aug; 29(6):371-80. PubMed ID: 24315804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis.
    Goldsmith DR; Haroon E; Miller AH; Addington J; Bearden C; Cadenhead K; Cannon T; Cornblatt B; Mathalon D; McGlashan T; Seidman L; Tsuang M; Woods SW; Walker EF; Perkins DO
    Brain Behav Immun; 2019 Feb; 76():268-274. PubMed ID: 30496778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal relationship between onset of positive and negative symptoms in the course of attenuated psychotic illness.
    Dishy G; Kennedy L; Lundgren B; Xu Q; Masucci MD; Califano A; Hesson H; Cohen-Romano C; Pia T; Brucato G
    Psychiatry Res; 2020 Nov; 293():113439. PubMed ID: 32942088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive validity of conversion from the clinical high risk syndrome to frank psychosis.
    Yoviene Sykes LA; Ferrara M; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Mathalon DH; Seidman LJ; Tsuang MT; Walker EF; McGlashan TH; Woodberry KA; Powers AR; Ponce AN; Cahill JD; Pollard JM; Srihari VH; Woods SW
    Schizophr Res; 2020 Feb; 216():184-191. PubMed ID: 31864837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive validity of psychosis risk models when applied to adolescent psychiatric patients.
    Lindgren M; Kuvaja H; Jokela M; Therman S
    Psychol Med; 2023 Jan; 53(2):547-558. PubMed ID: 34024309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further evidence that antipsychotic medication does not prevent long-term psychosis in higher-risk individuals.
    Zhang T; Wang J; Xu L; Wei Y; Tang X; Hu Y; Cui H; Tang Y; Li C; Ling Z; Wang J
    Eur Arch Psychiatry Clin Neurosci; 2022 Jun; 272(4):591-602. PubMed ID: 34536114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-converters.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Schizophr Res; 2017 Nov; 189():19-26. PubMed ID: 28139360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.